Recently published research shows that a medical device may be beneficial for patients who have previously had a stroke and are planning to undergo a transcatheter aortic valve replacement, a type of ...

CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

BOSTON, MA—Those who were hoping that PROTECTED TAVR would provide a clear-cut result and bring closure to the question of whether cerebral embolic protection (CEP) reduces stroke in patients ...

Using cerebral embolic protection devices during transcatheter aortic valve implantation (TAVI) procedures does not reduce a patient's risk of experiencing a stroke, according to a large UK clinical ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...

This article describes the clinical and economic impact of ischemic stroke, including the particular burden of recurrent stroke. Thereafter, it reviews the treatment landscape for recurrent stroke, ...

ABU DHABI, UAE — Extending the simple CT angiography (CTA) scan given to all patients with acute stroke on presentation to the hospital to include the upper part of the heart increased the detection ...